eli lilly
Entity, reached from Hormuz.
- Evidence
- 290 documents · 91 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 May 2026, last seen 9 Oct 2026
- Measured
- 28% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- MarketBeat News Feed · 2026-10-08 · HWG Holdings LP Buys 6,647 Shares of Eli Lilly and Company $LLY (opens the source in a new tab)
- MarketBeat News Feed · 2026-10-08 · Cantor Fitzgerald Issues Positive Forecast for Eli Lilly and Company (NYSE:LLY) Stock Price (opens the source in a new tab)
- European Medical Journal · 2026-10-03 · Forghorn slashes workforce by 40% after deal with Eli Lilly ends (opens the source in a new tab)
- Endpoints News · 2026-10-03 · Eli Lilly’s best-ever weight loss data; Sanofi, Regeneron re-up for $1B upfront; and more (opens the source in a new tab)
- UNKNOWN (source name missing from feed) · 2026-10-03 · Eli Lilly, Purdue to share field learnings on human robot interaction at RoboBusiness (opens the source in a new tab)
- STAT News · 2026-10-01 · STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial (opens the source in a new tab)
- Fierce Pharma · 2026-09-29 · Eli Lilly's new initiative will take GLP-1s to lower-income nations (opens the source in a new tab)
- PR Daily · 2026-09-28 · The Scoop: Eli Lilly defends presence at Vogue World (opens the source in a new tab)
- 24/7 Wall St. · 2026-09-28 · Eli Lilly Wavered Over the Last Month: One of Wall Street’s Biggest Banks Says 35% Gains Still to Come (opens the source in a new tab)
- Fierce Pharma · 2026-09-26 · Eli Lilly blasted for ‘promotional and emotive’ language in GLP-1 press release (opens the source in a new tab)
2 more on file, counted in the evidence above.
What is claimed about it
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- With FDA approval, Lilly’s BTK drug Jaypirca enters first-line CLL Could not check · a claim about it
Situations it is named in
Who it moves with
- co-mentioned with glp-1 (96 documents)seen together
- co-mentioned with fda (83 documents)seen together
- co-mentioned with ai (79 documents)seen together
- co-mentioned with novo nordisk (56 documents)seen together
- co-mentioned with studie (51 documents)seen together
- co-mentioned with trump (42 documents)seen together
- co-mentioned with zepbound (41 documents)seen together
- co-mentioned with united states (40 documents)seen together
- co-mentioned with novartis (39 documents)seen together